Federal Register / Vol. 61, No. 99 / Tuesday, May 21, 1996 / Notices 25493

1Copies of the Consent Order and Set Aside

Order are available from the Commission’s Public

Reference Branch, H–130, 6th Street and

Pennsylvania Avenue, N.W., Washington, D.C.

20580.

1Copies of the Complaint and the Decision and

Order are available from the Commission’s Public

Reference Branch, H–130, 6th Street and

Pennsylvania Avenue NW., Washington, DC 20580.

1Copies of the Complaint, the Decision and

Order, and Commissioner Azuenaga’s statement are

available from the Commission’s Public Reference

Branch, H–130, 6th Street & Pennsylvania Avenue,

N.W., Washington, D.C. 20580.

Board of Governors of the Federal Reserve

System, May 15, 1996.

Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 96–12682 Filed 5–20–96; 8:45 am]

BILLING CODE 6210–01–F

FEDERAL TRADE COMMISSION

[Dkt. No. 5794]

Atlas Supply Company; Prohibited

Trade Practices and Affirmative

Corrective Actions

AGENCY: Federal Trade Commission.

ACTION: Set aside order.

SUMMARY: This order reopens a 1951

consent order—which prohibited Atlas

from receiving illegal allowances or

knowingly accepting or inducing

discriminatory prices in their purchase

of automotive tires, tubes, batteries,

accessories or other automobile

products—and sets aside the consent

order pursuant to the Commission’s

Sunset Policy Statement, under which

the Commission presumes that the

public interest requires terminating

competition orders that are more than

20 years old.

DATES: Consent order issued July 19,

1951. Set aside order issued August 24,

1995.1

FOR FURTHER INFORMATION CONTACT:

Daniel Ducore, FTC/S–2115,

Washington, D.C. 20580, (202) 326–

2526.

SUPPLEMENTARY INFORMATION: In the

Matter of Atlas Supply Company. The

prohibited trade practices and/or

corrective actions are removed as

indicated.

(Sec. 6, 38 Stat. 721; 15 U.S.C. 46. Interpret

or apply sec. 5, 38 Stat. 719, as amended;

Sec. 2, 49 Stat. 1526; 15 U.S.C. 45, 13)

Donald S. Clark,

Secretary.

[FR Doc. 96–12700 Filed 5–20–96; 8:45 am]

BILLING CODE 6750–01–M

[Dkt. C–3633]

Blenheim Expositions, Inc.; Prohibited

Trade Practices, and Affirmative

Corrective Actions

AGENCY: Federal Trade Commission.

ACTION: Consent order.

SUMMARY: In settlement of alleged

violations of federal law prohibiting

unfair or deceptive acts or practices and

unfair methods of competition, this

consent order prohibits, among other

things, a Florida-based company, that

produces franchise trade shows and

expositions, from misrepresenting the

sales, income or profits, or the success

rate of franchise owners, unless it

possesses and relies upon competent

and reliable scientific evidence to

support the claims. In addition, the

respondent is prohibited from

misrepresenting the validity, results,

contents, conclusions, or interpretations

of any survey, test, poll or study.

DATES: Complaint and Order issued

December 22, 1995.1

FOR FURTHER INFORMATION CONTACT:

Tom Cohn, FTC/H–238, Washington,

DC 20580, (202) 326–3532.

SUPPLEMENTARY INFORMATION: On

Thursday, October 12, 1995, there was

published in the Federal Register, 60 FR

53186, a proposed consent agreement

with analysis In the Matter of Blenheim

Expositions, Inc., for the purpose of

soliciting public comment. Interested

parties were given sixty (60) days in

which to submit comments, suggestions

or objections regarding the proposed

form of the order.

No comments having been received,

the Commission has ordered the

issuance of the complaint in the form

contemplated by the agreement, made

its jurisdictional findings and entered

an order to cease and desist, as set forth

in the proposed consent agreement, in

disposition of this proceeding.

(Sec. 6, 38 Stat. 721; 15 U.S.C. 46. Interprets

or applies sec. 5, 38 Stat. 719, as amended;

15 U.S.C. 45)

Donald S. Clark,

Secretary.

[FR Doc. 96–12701 Filed 5–20–96; 8:45 am]

BILLING CODE 6750–01–M

[Dkt. C–3650]

Devro International plc, et al.;

Prohibited Trade Practices, and

Affirmative Corrective Actions

AGENCY: Federal Trade Commission.

ACTION: Consent order.

SUMMARY: In settlement of alleged

violations of federal law prohibiting

unfair or deceptive acts or practices and

unfair methods of competition, this

consent order requires, among other

things, the respondents to divest, within

three months to a Commission-approved

acquirer, the assets they use to produce

collagen sausage casings in the United

States and Canada. If the transaction is

not completed in the prescribed time,

the Commission may appoint a trustee

to divest the assets.

DATES: Complaint and Order issued

April 3, 1996.1

SUPPLEMENTARY INFORMATION: On

Tuesday, December 19, 1995, there was

published in the Federal Register, 60 FR

65328, a proposed consent agreement

with analysis In the Matter of Devro

International plc, et al., for the purpose

of soliciting public comment. Interested

parties were given sixty (60) days in

which to submit comments, suggestions

or objections regarding the proposed

form of the order.

Comments were filed and considered

by the Commission. The Commission

has ordered the issuance of the

complaint in the form contemplated by

the agreement, made its jurisdictional

findings and entered an order to divest,

as set forth in the proposed consent

agreement, in disposition of this

proceeding.

(Sec. 6, 38 Stat. 721; 15 U.S.C. 46. Interpret

or apply sec. 5, 38 Stat. 719, as amended; sec.

7, 38 Stat. 731, as amended; 15 U.S.C. 45, 18)

Donald S. Clark,

Secretary

[FR Doc. 96–12702 Filed 5–20–96; 8:45 am]

BILLING CODE 6750–01–M

[Dkt. C–3636]

Johnson & Johnson Consumer

Products, Inc.; Prohibited Trade

Practices, and Affirmative Correction

Actions

AGENCY: Federal Trade Commission.

ACTION: Consent order.

SUMMARY: In settlement of alleged

violations of federal law prohibiting

unfair or deceptive acts or practices and

unfair methods of competition, this

consent order prohibits, among other

things, a New Jersey-based personal

health-care products company and its

parent corporation from misrepresenting

the results or conclusions of any test or

study concerning any over-the-counter

products with a use relating to human

reproduction, reproductive organs or

sexually transmitted diseases (STDs). It

requires the respondent to have

competent and reliable scientific

evidence for any claims regarding the

efficacy of over-the-counter

contraceptives or products to protect